Bloomberg Originals
Bloomberg Originals
@business·5.1M subscribers·49.5K videos

Expect Consolidation in Pharma, But Not From Merck: CEO

Posted

June 29, 2015

Views

636

Likes

2

Engagement

0.31%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

YouTube Description

as posted by the channel

June 29 -- Merck Chairman of the Executive Board and CEO Karl-Ludwig Kley discusses his company’s acquisition of Sigma-Aldrich, consolidation in the Pharmaceuticals and the outlook for the sector. He speaks to Bloomberg’s Anna Edwards on “Countdown.”

Guests & Subjects Covered

Merck ChairmanExecutive BoardCEO Karl-Ludwig KleyBloombergs Anna Edwards

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.

Expect Consolidation in Pharma, But Not From Merck: CEO · Bloomberg Originals · Sentinel